Greenselect phytosome for borderline metabolic syndrome

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Belcaro, Gianni ^a   Ledda, Andrea ^a   Hu, Shu ^a   Cesarone, Maria Rosa ^a   Feragalli, Beatrice ^a   Dugall, Mark ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; GREEN TEA EXTRACT; GREENSELECT PHYTOSOME; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MONCAM; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; BODY MASS; BORDERLINE METABOLIC SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTENTION TO TREAT ANALYSIS; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LOW CALORY DIET; MALE; METABOLIC DISORDER; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARALLEL DESIGN; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 84890047965     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/869061     Document Type: Article

References (59)

1. Bansal S., Syan N., Mathur P., Choudhary S., Pharmacological profile of green tea and its polyphenols: a review. Medicinal Chemistry Research 2012 21 11 3347 3360
2. Yang C. S., Wang X., Green tea and cancer prevention. Nutrition and Cancer 2010 62 7 931 937 2-s2.0-77958020749 10.1080/01635581.2010.509536
3. Boehm K., Borrelli F., Ernst E., Habacher G., Hung S. K., Milazzo S., Horneber M., Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews 2009 3 10.1002/14651858.CD005004 CD005004 2-s2.0-68549110986
4. Jurgens T. M., Whelan A. M., Killian L., Doucette S., Kirk S., Foy E., Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database of Systematic Reviews 2012 12 CD008650
5. Hursel R., Viechtbauer W., Westerterp-Plantenga M. S., The effects of green tea on weight loss and weight maintenance: a meta-analysis. International Journal of Obesity 2009 33 9 956 961 2-s2.0-70349120321 10.1038/ijo.2009.135
6. Park J. H., Jin J. Y., Baek W. K., Park S. H., Sung H. Y., Kim Y. K., Lee J., Song D.-K., Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption. Journal of Physiology and Pharmacology 2009 60 4 101 109 2-s2.0-75749131628
7. Maruyama K., Iso H., Sasaki S., Fukino Y., The association between concentrations of green tea and blood glucose levels. Journal of Clinical Biochemistry and Nutrition 2009 44 1 41 45 2-s2.0-60849133607 10.3164/jcbn.08-13
8. Miura T., Koike T., Ishida T., Antidiabetic activity of green tea (Thea sinensis L.) in genetically type 2 diabetic mice. Journal of Health Science 2005 51 6 708 710 2-s2.0-28444440925 (Pubitemid 41739068)
9. Waltner-Law M. E., Wang X. L., Law B. K., Hall R. K., Nawano M., Granner D. K., Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. Journal of Biological Chemistry 2002 277 38 34933 34940 2-s2.0-0037144406 10.1074/jbc.M204672200
10. Ogden C. L., Carroll M. D., Kit B. K., Flegal K. M., Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012 82 1 8
11. Kumanyika S., Jeffery R. W., Morabia A., Ritenbaugh C., Antipatis V. J., Obesity prevention: the case for action. International Journal of Obesity 2002 26 3 425 436 2-s2.0-0036129738 10.1038/sj/ijo/0801938 (Pubitemid 34226170)
12. Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 2007 356 3 213 215 2-s2.0-33846422032 10.1056/NEJMp068177 (Pubitemid 46143224)
13. Bose M., Lambert J. D., Ju J., Reuhl K. R., Shapses S. A., Yang C. S., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. Journal of Nutrition 2008 138 9 1677 1683 2-s2.0-51049094422
14. Nagao T., Hase T., Tokimitsu I., A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007 15 6 1473 1483 2-s2.0-34547161951 10.1038/oby.2007.176 (Pubitemid 47110911)
15. Dulloo A. G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., Chantre P., Vandermander J., Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. American Journal of Clinical Nutrition 1999 70 6 1040 1045 2-s2.0-0032805656
16. Wolfram S., Wang Y., Thielecke F., Anti-obesity effects of green tea: from bedside to bench. Molecular Nutrition and Food Research 2006 50 2 176 187 2-s2.0-33644643539 10.1002/mnfr.200500102 (Pubitemid 43325659)
17. Shixian Q., VanCrey B., Shi J., Kakuda Y., Jiang Y., Green tea extract thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-O-methyltransferase. Journal of Medicinal Food 2006 9 4 451 458 2-s2.0-33846213535 (Pubitemid 46095351)
18. Di Pierro F., Menghi A. B., Barreca A., Lucarelli M., Calandrelli A., GreenSelect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Alternative Medicine Review 2009 14 2 154 160 2-s2.0-67650983239
19. Zheng G., Sayama K., Okubo T., Juneja L. R., Oguni I., Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 2004 18 1 55 62 2-s2.0-1342304952 (Pubitemid 38263372)
20. Greenberg J. A., Boozer C. N., Geliebter A., Coffee, diabetes, and weight control. American Journal of Clinical Nutrition 2006 84 4 682 693 2-s2.0-33750613195 (Pubitemid 44715648)
21. Boschmann M., Thielecke F., The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. The Journal of the American College of Nutrition 2007 26 4 389S 395S (Pubitemid 47579908)
22. Gosselin C., Haman F., Effects of green tea extracts on non-shivering thermogenesis during mild cold exposure in young men. British Journal of Nutrition 2013 110 2 282 288
23. Pietta P., Simonetti P., Gardana C., Brusamolino A., Morazzoni P., Bombardelli E., Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochemistry and Molecular Biology International 1998 46 5 895 903 2-s2.0-0032425664 (Pubitemid 29004600)
24. Alberti G., Zimmet P., Shaw J., Grundy S. M., The IDF Consensus Worldwide Definition of the Metabolic Syndrome, IDF Communications 2006 Brussels, Belgium
25. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., Alberiche M., Bonadonna R. C., Muggeo M., Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998 47 10 1643 1649 2-s2.0-0031710787 10.2337/diabetes.47.10.1643 (Pubitemid 28445355)
26. Brunzell J. D., Ayyobi A. F., Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. American Journal of Medicine A 2003 115 supplement 8 24S 28S
27. Nesto R. W., The relation of insulin resistance syndromes to risk of cardiovascular disease. Reviews in Cardiovascular Medicine 2003 4 6 S11 S18 2-s2.0-0347532623 (Pubitemid 37526931)
28. Pouliot M.-C., Despres J.-P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., Nadeau A., Lupien P. J., Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. American Journal of Cardiology 1994 73 7 460 468 2-s2.0-0028299585 10.1016/0002-9149(94) 90676-9 (Pubitemid 24096208)
29. Lindström J., Louheranta A., Mannelin M., Rastas M., Salminen V., Eriksson J., Uusitupa M., Tuomilehto J., The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003 26 12 3230 3236 2-s2.0-0345707499 10.2337/diacare.26.12.3230 (Pubitemid 37466880)
30. Robins S. J., Collins D., Wittes J. T., Papademetriou V., Deedwania P. C., Schaefer E. J., McNamara J. R., Kashyap M. L., Hershman J. M., Wexler L. F., Rubins H. B., Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: a randomized controlled trial. Journal of the American Medical Association 2001 285 12 1585 1591 2-s2.0-0035962077 (Pubitemid 32240250)
31. Tuomilehto J., Lindström J., Eriksson J. G., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 2001 344 18 1343 1350 (Pubitemid 32378388)
32. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L. Jr., Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr., Roccella E. J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
33. Collins R., Armitage J., Parish S., Sleigh P., Peto R., MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. The Lancet 2003 361 9374 2005 2016
34. Haffner S. M., Alexander C. M., Cook T. J., Boccuzzi S. J., Musliner T. A., Pedersen T. R., Kjekshus J., Pyörälä K., Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the scandinavian simvastatin survival study. Archives of Internal Medicine 1999 159 22 2661 2667 2-s2.0-0033611310 10.1001/archinte.159.22.2661
35. Chiasson J.-L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Journal of the American Medical Association 2003 290 4 486 494 2-s2.0-0038455703 10.1001/jama.290.4.486 (Pubitemid 37430502)
36. Knowler W. C., Barrett-Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., Nathan D. M., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 2002 346 6 393 403 2-s2.0-0037034257 10.1056/NEJMoa012512 (Pubitemid 34437694)
37. Torgerson J. S., Hauptman J., Boldrin M. N., Sjöström L., XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004 27 1 155 161 2-s2.0-1042303480 10.2337/diacare.27.1.155 (Pubitemid 38196725)
38. Romero C. X., Romero T. E., Shlay J. C., Ogden L. G., Dabelea D., Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Advances in Preventive Medicine 2012 2012 8 10.1155/2012/172423 172423
39. Goldstein M. R., Mascitelli L., Pezzetta F., On treating metabolic syndrome: emphasise lifestyle change. The Lancet Oncology 2010 11 5, article 415 2-s2.0-77952302027 10.1016/S1470-2045(10)70055-3
40. Wilsgaard T., Jacobsen B. K., Lifestyle factors and incident metabolic syndrome. The Tromsø Study 1979-2001. Diabetes Research and Clinical Practice 2007 78 2 217 224 2-s2.0-34548839093 10.1016/j.diabres.2007.03.006 (Pubitemid 47451522)
41. Kirk R. E., Experimental Design: Procedures for the Behavioral Sciences 1982 Belmont, Mass, USA Brooks/Cole
42. Basu A., Betts N. M., Mulugeta A., Tong C., Newman E., Lyons T. J., Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutrition Research 2013 33 3 180 187
43. Vieira Senger A. E., Schwanke C. H., Gomes I., Valle Gottlieb M. G., Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. The Journal of Nutrition, Health & Aging 2012 16 9 738 742
44. Bérubé-Parent S., Pelletier C., Doré J., Tremblay A., Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. British Journal of Nutrition 2005 94 3 432 436 2-s2.0-26044451440 10.1079/BJN20051502 (Pubitemid 41404286)
45. Hill A. M., Coates A. M., Buckley J. D., Ross R., Thielecke F., Howe P. R. C., Can EGCG reduce abdominal fat in obese subjects? Journal of the American College of Nutrition 2007 26 4 396S 402S 2-s2.0-35348880332 (Pubitemid 47579909)
46. Maki K. C., Reeves M. S., Farmer M., Yasunaga K., Matsuo N., Katsuragi Y., Komikado M., Tokimitsu I., Wilder D., Jones F., Blumberg J. B., Cartwright Y., Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. Journal of Nutrition 2009 139 2 264 270 2-s2.0-60249092410 10.3945/jn.108.098293
47. Komatsu T., Nakamori M., Komatsu K., Hosoda K., Okamura M., Toyama K., Ishikura Y., Sakai T., Kunii D., Yamamoto S., Oolong tea increases energy metabolism in Japanese females. Journal of Medical Investigation 2003 50 3-4 170 175 2-s2.0-0346880370 (Pubitemid 38019764)
48. Rumpler W., Seale J., Clevidence B., Judd J., Wiley E., Yamamoto S., Komatsu T., Sawaki T., Ishikura Y., Hosoda K., Oolong tea increases metabolic rate and fat oxidation in men. Journal of Nutrition 2001 131 11 2848 2852 2-s2.0-0035166771 (Pubitemid 33063113)
49. Pietta P., Simonetti P., Gardana C., Brusamolino A., Morazzoni P., Bombardelli E., Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochemistry and Molecular Biology International 1998 46 5 895 903 2-s2.0-0032425664 (Pubitemid 29004600)
50. Hursel R., Viechtbauer W., Dulloo A. G., Tremblay A., Tappy L., Rumpler W., Westerterp-Plantenga M. S., The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis. Obesity Reviews 2011 12 7 e573 e581 2-s2.0-79959231714 10.1111/j.1467-789X.2011.00862.x
51. Beaudoin M. S., Allen B., Mazzetti G., Sullivan P. J., Graham T. E., Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women. Applied Physiology, Nutrition, and Metabolism 2013 38 2 140 147
52. Belcaro G., Cesarone M., Silvia E., Ledda A., Stuard S., Vinciguerra G., Dougall M., Cornelli U., Hastings C., Schönlau F., Daily consumption of reliv glucaffect ™ for 8 weeks significantly lowered blood glucose and body weight in 50 subjects. Phytotherapy Research 2009 23 12 1673 1677 2-s2.0-73449117201 10.1002/ptr.2793
53. Boon N., Health potential for functional green teas? International Journal for Vitamin and Nutrition Research 2008 78 6 275 281 2-s2.0-69549113092 10.1024/0300-9831.78.6.275
54. Adar T., Ben Ya'acov A., Lalazar G., Lichtenstein Y., Nahman D., Mizrahi M., Wong V., Muller B., Rawlin G., Ilan Y., Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells. Clinical and Experimental Immunology 2012 167 2 252 260 2-s2.0-84855777705 10.1111/j.1365-2249.2011.04511.x
55. Gupta N., Goel K., Shah P., Misra A., Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocrine Reviews 2012 33 1 48 70 2-s2.0-84857845479 10.1210/er.2010-0028
56. Nguyen Dinh Cat A., Jaisser F., Extrarenal effects of aldosterone. Current Opinion in Nephrology and Hypertension 2012 21 2 147 156 2-s2.0-84857041383 10.1097/MNH.0b013e32834fb25b
57. Soares-Miranda L., Sandercock G., Vale S., Metabolic syndrome, physical activity and cardiac autonomic function. Diabetes/Metabolism Research and Reviews 2012 28 4 363 369
58. Stelzer I., Zelzer S., Raggam R. B., Prüller F., Truschnig-Wilders M., Meinitzer A., Schnedl W. J., Horejsi R., Möller R., Weghuber D., Reeves G., Postolache T. T., Mangge H., Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Translational Research 2012 159 2 118 124 2-s2.0-84855862378 10.1016/j.trsl.2011.10.001
59. Barac A., Wang H., Shara N. M., de Simone G., Carter E. A., Umans J. G., Best L. G., Yeh J., Dixon D. B., Devereux R. B., Howard B. V., Panza J. A., Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the strong heart study. Journal of Clinical Hypertension 2012 14 1 13 19 2-s2.0-84855344076 10.1111/j.1751-7176.2011.00560.x